Gujarat Kidney And Super Speciality Limited: Certificate under SEBI Regulations 74(5)
Gujarat Kidney And Super Speciality Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The certificate confirms proper processing of dematerialised securities by the Share Transfer Agent, MUFG Intime India Private Limited, ensuring compliance with depository regulations.
This is a standard regulatory compliance filing related to share dematerialization and does not have a significant impact on the company's business operations or financial standing.
The announcement is a routine compliance filing regarding share transfer agent activities and does not contain any financial performance indicators or strategic business updates.
Gujarat Kidney And Super Speciality Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate was received from the Company's Share Transfer Agent, MUFG Intime India Private Limited.
The certificate confirms that for the third quarter ended December 31, 2025, all dematerialised securities received from depository participants were processed (accepted/rejected) within the prescribed timelines. Furthermore, the security certificates received for dematerialisation were duly verified, cancelled, and replaced with the depository's name in the register of members as the registered owner.
This compliance filing ensures adherence to SEBI regulations regarding the handling of securities and depositories.
What to do with a filing like this
Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.